DataMeds AI, Inc. Increase Decrease In Operating Lease Liability
DataMeds AI, Inc. (MEDS) reported Increase Decrease In Operating Lease Liability of -$32.91 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-17
- DataMeds AI, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$18.05K.
- DataMeds AI, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$14.86K.
- DataMeds AI, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$14.57K, a 965.66% decline year-over-year.
- DataMeds AI, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was $62.03K.
- DataMeds AI, Inc. increase decrease in operating lease liability for fiscal 2025 was $41.75K, a 88.97% increase from fiscal 2024.
- DataMeds AI, Inc. increase decrease in operating lease liability for fiscal 2024 was $22.09K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$18.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$32.91K 10-Q · filed 2026-08-17 | -$47.48K derived: sum of 3 quarters · filed 2026-08-17 | $14.56K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | -$14.86K 10-Q · filed 2026-05-19 | -$29.43K derived: sum of 2 quarters · filed 2026-05-19 | $32.61K derived: sum of 3 quarters · filed 2026-05-19 | $28.19K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | -$14.57K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $47.47K derived: sum of 2 quarters · filed 2026-03-20 | $43.05K derived: sum of 3 quarters · filed 2026-08-17 | $41.75K 10-K · filed 2026-03-20 |
| 2025-09-30 | $62.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $57.62K derived: sum of 2 quarters · filed 2026-08-17 | $56.31K 10-Q · filed 2025-11-19 | $58.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$4.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$5.72K 10-Q · filed 2026-08-17 | -$4.04K derived: sum of 3 quarters · filed 2026-08-17 | -$5.74K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | -$1.31K 10-Q · filed 2026-05-19 | $376.00 derived: sum of 2 quarters · filed 2026-05-19 | -$1.33K derived: sum of 3 quarters · filed 2026-05-19 | |
| 2024-12-31 | $1.68K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$23.00 derived: sum of 2 quarters · filed 2026-03-20 | $22.09K 10-K · filed 2026-03-20 | |
| 2024-09-30 | -$1.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $20.41K 10-Q · filed 2025-11-19 | ||
| 2024-06-30 | $22.11K 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |